Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis

Leishmaniasis, as a tropical and subtropical disease, is endemic in more than 90 countries around the world. Today, cutaneous leishmaniasis (CL) that affects more than 1.5 million people per year lacks a definitive treatment approach. Imatinib is an anticancer drug that inhibits the abnormal functio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AIMS Microbiol
Autors principals: Moslehi, Mohsen, Namdar, Fatemeh, Esmaeilifallah, Mahsa, Iraji, Fariba, Vakili, Bahareh, Sokhanvari, Fatemeh, Hosseini, Seyed-Mohsen, Khamesipour, Faham, Sebghatollahi, Zahra, Hejazi, Sayed-Hossein
Format: Artigo
Idioma:Inglês
Publicat: AIMS Press 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7326727/
https://ncbi.nlm.nih.gov/pubmed/32617447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3934/microbiol.2020010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars